Parents' Experience of Child Loss During Pregnancy or Birth
Launched by FRITZ STERR · Jan 7, 2025
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the experiences of parents who have lost a child during pregnancy or birth, focusing on stillbirth, fetal death, and miscarriages. The goal is to understand how to better support these parents and to develop recommendations for healthcare professionals on how to communicate and provide care during such difficult times.
To participate in this study, you need to be a German-speaking parent living in Austria, Germany, or Switzerland who has experienced the loss of a child within the last 12 months. It's important that you feel mentally prepared to share your experience, as this study aims to gather firsthand insights from parents. If you join the study, you can expect to share your thoughts and feelings about your loss, which will help improve how healthcare providers support families in similar situations. This trial is currently recruiting participants, and your voice can contribute to making a difference for others facing this heartbreaking experience.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • German speaking
- • Living in Austria, Germany or Switzerland
- • Child loss during pregnancy or birth
- • Child loss within last 12 months
- • Legal capacity
- • Voluntary participation
- Exclusion Criteria:
- • Loss of child after birth
- • Not speaking and understanding German
- • Not in a good mental condition to participate
About Fritz Sterr
Fritz Sterr is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a strong emphasis on ethical practices and regulatory compliance, Fritz Sterr collaborates closely with healthcare professionals and research institutions to design and implement rigorous clinical studies. The organization focuses on a diverse range of therapeutic areas, leveraging state-of-the-art methodologies and technologies to ensure the highest standards of data integrity and patient safety. Through its commitment to scientific excellence and patient-centered research, Fritz Sterr aims to contribute significantly to the development of transformative healthcare interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Deggendorf, Bavaria, Germany
Patients applied
Trial Officials
Christian Rester, Prof. Dr.
Study Chair
Deggendorf Institute of Technology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported